| Targets for combating the evolution of acquired antibiotic resistance MJ Culyba, CY Mo, RM Kohli Biochemistry 54 (23), 3573-3582, 2015 | 144 | 2015 |
| Type III-A CRISPR-Cas Csm complexes: assembly, periodic RNA cleavage, DNase activity regulation, and autoimmunity N Jia, CY Mo, C Wang, ET Eng, LA Marraffini, DJ Patel Molecular cell 73 (2), 264-277. e5, 2019 | 92 | 2019 |
| Systematically altering bacterial SOS activity under stress reveals therapeutic strategies for potentiating antibiotics CY Mo, SA Manning, M Roggiani, MJ Culyba, AN Samuels, ... MSphere 1 (4), 10.1128/msphere. 00163-16, 2016 | 81 | 2016 |
| Inhibitors of LexA autoproteolysis and the bacterial SOS response discovered by an academic–industry partnership CY Mo, MJ Culyba, T Selwood, JM Kubiak, ZM Hostetler, AJ Jurewicz, ... ACS infectious diseases 4 (3), 349-359, 2017 | 54 | 2017 |
| Dynamics of Cas10 govern discrimination between self and non-self in type III CRISPR-Cas immunity L Wang, CY Mo, MR Wasserman, JT Rostøl, LA Marraffini, S Liu Molecular cell 73 (2), 278-290. e4, 2019 | 48 | 2019 |
| Non-equilibrium repressor binding kinetics link DNA damage dose to transcriptional timing within the SOS gene network MJ Culyba, JM Kubiak, CY Mo, M Goulian, RM Kohli PLoS genetics 14 (6), e1007405, 2018 | 44 | 2018 |
| Specificity determinants for autoproteolysis of LexA, a key regulator of bacterial SOS mutagenesis CY Mo, LD Birdwell, RM Kohli Biochemistry 53 (19), 3158-3168, 2014 | 36 | 2014 |
| Type III-A CRISPR immunity promotes mutagenesis of staphylococci CY Mo, J Mathai, JT Rostøl, A Varble, DV Banh, LA Marraffini Nature 592 (7855), 611-615, 2021 | 31 | 2021 |
| High-throughput mutagenesis reveals functional determinants for DNA targeting by activation-induced deaminase KS Gajula, PJ Huwe, CY Mo, DJ Crawford, JT Stivers, R Radhakrishnan, ... Nucleic acids research 42 (15), 9964-9975, 2014 | 26 | 2014 |
| Advancement of the 5-amino-1-(carbamoylmethyl)-1H-1, 2, 3-triazole-4-carboxamide scaffold to disarm the bacterial SOS response T Selwood, BJ Larsen, CY Mo, MJ Culyba, ZM Hostetler, RM Kohli, ... Frontiers in Microbiology 9, 2961, 2018 | 24 | 2018 |
| Inhibitors of LexA Autoproteolysis and the Bacterial SOS Response Discovered by an Academic-Industry Partnership. ACS Infect. Dis 4 (3): 349–359 CY Mo, MJ Culyba, T Selwood, JM Kubiak, ZM Hostetler, AJ Jurewicz, ... American Chemical Society. doi, 2018 | 8 | 2018 |
| A small-molecule inducible synthetic circuit for control of the SOS gene network without DNA damage JM Kubiak, MJ Culyba, MY Liu, CY Mo, M Goulian, RM Kohli ACS Synthetic Biology 6 (11), 2067-2076, 2017 | 5 | 2017 |
| If you’d like to stop a type III CRISPR ribonuclease, then you should put a ring (nuclease) on it CY Mo, LA Marraffini Molecular cell 72 (4), 608-609, 2018 | 1 | 2018 |
Luciano MarraffiniThe Rockefeller UniversityVerified email at rockefeller.edu
